fashion -WSS

fashion

author：focus 2025-09-30 18:17:11 - browse：13

Two people run on the sugar-phosphate backbone of DNA while holding base pairs — in the lab coverage from STAT — Adobe

LONDON — Widespread genetic testing as well as the development of cutting-edge, customized genetic therapies have opened the door to treating many more inherited conditions than previously possible. A few recent cases, in which bespoke medicines were created for children with exceedingly rare mutations, have raised hopes for furthering the approach.

Now, researchers and government agencies in the U.K. are trying to figure out the nitty-gritty to replicate those early one-off successes for as many patients as possible — what sort of preclinical testing a tailor-made treatment needs to go through before being used, what regulatory thresholds each treatment needs to clear, and how to pay for these therapies.

“A lot of the barriers are no longer scientific — we can make these drugs,” said Matthew Wood, a professor of pediatrics at the University of Oxford. “It’s more about, can we make them at a cost that is reasonable enough? And can we get the regulators to reduce the barriers to doing this so that when a patient shows up, you can actually make a drug quickly enough to benefit that patient, rather than it costing huge amounts of money and taking two or three years to do it?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： The Readout: Lenmeldy, GLP

explore

WSS

For Medicare Advantage, Democrats want stronger protections around AI

Medicare Advantage proposed rates disappoint insurers

Supreme Court mifepristone arguments center on docs' right to sue

Patient advocates debate FDA's accelerated approval process

Abortion pill Supreme Court ruling could impact entire drug industry

What should King Charles tell the public about his cancer?

hotspot

fashion

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Donor acceptance rates hint at racial, gender bias in heart transplants: study

DIEP, the 'gold standard' of breast reconstruction, is under threat

BioAge raises $170M for combination therapy with Zepbound

Walensky prepares to leave CDC — and Congress — behind

Eliminate the waiting period for sterilization covered by Medicaid

Drug repurposing or repositioning? The language matters

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

How to save PrEP access — and even expand it

Oprah kicked off a national conversation on obesity. Let's have it

Wikipedia

What we’ve learned from the Aduhelm mess

Eliminate the waiting period for sterilization covered by Medicaid

Readout LOUD podcast: mifepristone case, GLP

A disappointing year of Humira biosimilars

Primary care physicians play key roles in Alzheimer's management

Steward Health Care has deal to sell doctor network to UnitedHealth

explore

hotspot

Wikipedia

hotspot